Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy

Krishnendu Roy, Hai Quan Mao, Shau Ku Huang, Kam W. Leong

Research output: Contribution to journalArticle

976 Citations (Scopus)

Abstract

Food allergy is a common and often fatal disease with no effective treatment. We describe here a new immunoprophylactic strategy using oral allergen-gene immunization to modulate peanut antigen-induced murine anaphylactic responses. Oral administration of DNA nanoparticles synthesized by complexing plasmid DNA with chitosan, a natural biocompatible polysaccharide, resulted in transduced gene expression in the intestinal epithelium. Mice receiving nanoparticles containing a dominant peanut allergen gene (pCMVArah2) produced secretory IgA and serum IgG2a. Compared with non-immunized mice or mice treated with 'naked' DNA, mice immunized with nanoparticles showed a substantial reduction in allergen-induced anaphylaxis associated with reduced levels of IgE, plasma histamine and vascular leakage. These results demonstrate that oral allergen-gene immunization with chitosan- DNA nanoparticles is effective in modulating murine anaphylactic responses, and indicate its prophylactic utility in treating food allergy.

Original languageEnglish
Pages (from-to)387-391
Number of pages5
JournalNature Medicine
Volume5
Issue number4
DOIs
Publication statusPublished - Apr 1 1999
Externally publishedYes

Fingerprint

Peanut Hypersensitivity
Allergies
Chitosan
Nanoparticles
Allergens
Genes
Immunization
Food Hypersensitivity
DNA
Secretory Immunoglobulin A
Anaphylaxis
Intestinal Mucosa
Gene expression
Immunoglobulin E
Histamine
Polysaccharides
Blood Vessels
Oral Administration
Plasmids
Plasmas

ASJC Scopus subject areas

  • Medicine(all)
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. / Roy, Krishnendu; Mao, Hai Quan; Huang, Shau Ku; Leong, Kam W.

In: Nature Medicine, Vol. 5, No. 4, 01.04.1999, p. 387-391.

Research output: Contribution to journalArticle

@article{b365bf2cad73417fa3da48d7f4d4d4bb,
title = "Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy",
abstract = "Food allergy is a common and often fatal disease with no effective treatment. We describe here a new immunoprophylactic strategy using oral allergen-gene immunization to modulate peanut antigen-induced murine anaphylactic responses. Oral administration of DNA nanoparticles synthesized by complexing plasmid DNA with chitosan, a natural biocompatible polysaccharide, resulted in transduced gene expression in the intestinal epithelium. Mice receiving nanoparticles containing a dominant peanut allergen gene (pCMVArah2) produced secretory IgA and serum IgG2a. Compared with non-immunized mice or mice treated with 'naked' DNA, mice immunized with nanoparticles showed a substantial reduction in allergen-induced anaphylaxis associated with reduced levels of IgE, plasma histamine and vascular leakage. These results demonstrate that oral allergen-gene immunization with chitosan- DNA nanoparticles is effective in modulating murine anaphylactic responses, and indicate its prophylactic utility in treating food allergy.",
author = "Krishnendu Roy and Mao, {Hai Quan} and Huang, {Shau Ku} and Leong, {Kam W.}",
year = "1999",
month = "4",
day = "1",
doi = "10.1038/7385",
language = "English",
volume = "5",
pages = "387--391",
journal = "Nature Medicine",
issn = "1078-8956",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy

AU - Roy, Krishnendu

AU - Mao, Hai Quan

AU - Huang, Shau Ku

AU - Leong, Kam W.

PY - 1999/4/1

Y1 - 1999/4/1

N2 - Food allergy is a common and often fatal disease with no effective treatment. We describe here a new immunoprophylactic strategy using oral allergen-gene immunization to modulate peanut antigen-induced murine anaphylactic responses. Oral administration of DNA nanoparticles synthesized by complexing plasmid DNA with chitosan, a natural biocompatible polysaccharide, resulted in transduced gene expression in the intestinal epithelium. Mice receiving nanoparticles containing a dominant peanut allergen gene (pCMVArah2) produced secretory IgA and serum IgG2a. Compared with non-immunized mice or mice treated with 'naked' DNA, mice immunized with nanoparticles showed a substantial reduction in allergen-induced anaphylaxis associated with reduced levels of IgE, plasma histamine and vascular leakage. These results demonstrate that oral allergen-gene immunization with chitosan- DNA nanoparticles is effective in modulating murine anaphylactic responses, and indicate its prophylactic utility in treating food allergy.

AB - Food allergy is a common and often fatal disease with no effective treatment. We describe here a new immunoprophylactic strategy using oral allergen-gene immunization to modulate peanut antigen-induced murine anaphylactic responses. Oral administration of DNA nanoparticles synthesized by complexing plasmid DNA with chitosan, a natural biocompatible polysaccharide, resulted in transduced gene expression in the intestinal epithelium. Mice receiving nanoparticles containing a dominant peanut allergen gene (pCMVArah2) produced secretory IgA and serum IgG2a. Compared with non-immunized mice or mice treated with 'naked' DNA, mice immunized with nanoparticles showed a substantial reduction in allergen-induced anaphylaxis associated with reduced levels of IgE, plasma histamine and vascular leakage. These results demonstrate that oral allergen-gene immunization with chitosan- DNA nanoparticles is effective in modulating murine anaphylactic responses, and indicate its prophylactic utility in treating food allergy.

UR - http://www.scopus.com/inward/record.url?scp=0032958073&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032958073&partnerID=8YFLogxK

U2 - 10.1038/7385

DO - 10.1038/7385

M3 - Article

C2 - 10202926

AN - SCOPUS:0032958073

VL - 5

SP - 387

EP - 391

JO - Nature Medicine

JF - Nature Medicine

SN - 1078-8956

IS - 4

ER -